abstract |
(57) The invention relates to the pharmaceutical industry, and more specifically to a method for producing a triticain-based drug - and for the treatment of celiac disease. The invention provides improved technological properties of triticain-α, which allows you to create the most suitable dosage form for its oral administration — solid hypromellose capsules. |